LEVY Health is a biotechnology and healthcare startup based in the United States that is making waves in the industry. Their clinical decision support software is revolutionizing the way OB-GYNs identify endocrine disorders and aiding fertility clinics in streamlining complex work-ups, ultimately reducing the time to diagnoses from years to mere weeks. This innovative approach ensures a more efficient and effective path to parenthood.
The startup was founded in 2020 and has already attracted a significant amount of investment. In the €800.00K Pre Seed Round investment at 15 May 2023, they secured funding from Springboard Health Angels and Ali Ciger, underlining the confidence that key players in the industry have in the potential of LEVY Health.
With their slogan "Empowering Providers, Building Families," LEVY Health is clearly focused on making a positive impact not only within the healthcare sector but also on a personal level for individuals and families. Their ability to combine cutting-edge technology with a human-centric approach positions them as a compelling investment opportunity in the healthcare and biotechnology landscape.